{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:27:21Z","timestamp":1792153641972,"version":"4.4.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK114425"],"award-info":[{"award-number":["R01 DK114425"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG LI2397\/5-1"],"award-info":[{"award-number":["DFG LI2397\/5-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["R01FD008225"],"award-info":[{"award-number":["R01FD008225"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","award":["GRT-ME-001683"],"award-info":[{"award-number":["GRT-ME-001683"]}],"id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["01GM2203B"],"award-info":[{"award-number":["01GM2203B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["739532"],"award-info":[{"award-number":["739532"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1804123N"],"award-info":[{"award-number":["1804123N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G060623N"],"award-info":[{"award-number":["G060623N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0C8920N"],"award-info":[{"award-number":["G0C8920N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["101080717"],"award-info":[{"award-number":["101080717"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1053\/j.ajkd.2025.01.022","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T13:23:22Z","timestamp":1742304202000},"page":"383-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Polycystic Kidney Disease in Children: The Current Status and the Next Horizon"],"prefix":"10.1053","volume":"86","author":[{"given":"Melissa A.","family":"Cadnapaphornchai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Dell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Gimpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Guay-Woodford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashima","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erum A.","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max C.","family":"Liebau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Mallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matko","family":"Marlais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djalila","family":"Mekahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alixandra","family":"Piccirilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Seeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Tindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.D.","family":"Winyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ajkd.2025.01.022_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1053\/j.ajkd.2025.01.022_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2023.151434","article-title":"Cystic kidney diseases in children and adults: differences and gaps in clinical management","volume":"43","author":"Hanna","year":"2023","journal-title":"Semin Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2025.01.022_bib3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/j.akdh.2023.01.005","article-title":"Autosomal recessive polycystic kidney disease: diagnosis, prognosis, and management","volume":"30","author":"Burgmaier","year":"2023","journal-title":"Adv Kidney Dis Health"},{"key":"10.1053\/j.ajkd.2025.01.022_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.21037\/tgh-2020-04","article-title":"Fibrocystic liver disease: novel concepts and translational perspectives","volume":"6","author":"Lasagni","year":"2021","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"12","key":"10.1053\/j.ajkd.2025.01.022_bib5","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1136\/archdischild-2015-310221","article-title":"Hypertension in autosomal dominant polycystic kidney disease: a meta-analysis","volume":"101","author":"Marlais","year":"2016","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1053\/j.ajkd.2025.01.022_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00467-022-05432-5","article-title":"Should we screen for intracranial aneurysms in children with autosomal dominant polycystic kidney disease?","volume":"38","author":"Walker","year":"2023","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2025.01.022_bib7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/hep.1840110619","article-title":"Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease","volume":"11","author":"Gabow","year":"1990","journal-title":"Hepatology"},{"issue":"6","key":"10.1053\/j.ajkd.2025.01.022_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/1097-0096(200007\/08)28:6<277::AID-JCU2>3.0.CO;2-L","article-title":"Abdominal sonographic study of autosomal dominant polycystic kidney disease","volume":"28","author":"Nicolau","year":"2000","journal-title":"J Clin Ultrasound"},{"issue":"1","key":"10.1053\/j.ajkd.2025.01.022_bib9","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.1038\/s41598-019-43488-w","article-title":"Clinical courses and complications of young adults with autosomal recessive polycystic kidney disease (ARPKD)","volume":"9","author":"Burgmaier","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1053\/j.ajkd.2025.01.022_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000200165.90373.9a","article-title":"Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD)","volume":"85","author":"Adeva","year":"2006","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1053\/j.ajkd.2025.01.022_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000448695","article-title":"Long-term outcomes in patients with very-early onset autosomal dominant polycystic kidney disease","volume":"44","author":"Nowak","year":"2016","journal-title":"Am J Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2025.01.022_bib12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00467-012-2192-y","article-title":"Early renal abnormalities in children with postnatally diagnosed autosomal dominant polycystic kidney disease","volume":"27","author":"Selistre","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2025.01.022_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/MPG.0b013e318228330c","article-title":"Congenital hepatic fibrosis and portal hypertension in autosomal dominant polycystic kidney disease","volume":"54","author":"O\u2019Brien","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1053\/j.ajkd.2025.01.022_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.34067\/KID.0000000000000064","article-title":"Hypomorphic PKD1 alleles impact disease variability in autosomal dominant polycystic kidney disease","volume":"4","author":"Gulati","year":"2023","journal-title":"Kidney360"},{"issue":"7","key":"10.1053\/j.ajkd.2025.01.022_bib15","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s00467-022-05834-5","article-title":"Kidney concentrating capacity in children with autosomal recessive polycystic kidney disease is linked to glomerular filtration and hypertension","volume":"38","author":"Seeman","year":"2023","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2025.01.022_bib16","first-page":"629","article-title":"Renal concentrating capacity is linked to blood pressure in children with autosomal dominant polycystic kidney disease","volume":"53","author":"Seeman","year":"2004","journal-title":"Physiol Res"},{"issue":"6","key":"10.1053\/j.ajkd.2025.01.022_bib17","doi-asserted-by":"crossref","first-page":"874","DOI":"10.2215\/CJN.11401017","article-title":"Prevalence of hypertension in children with early-stage ADPKD","volume":"13","author":"Massella","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2025.01.022_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1112727","article-title":"Autosomal dominant and autosomal recessive polycystic kidney disease: hypertension and secondary cardiovascular effect in children","volume":"10","author":"Lucchetti","year":"2023","journal-title":"Front Mol Biosci"},{"issue":"1","key":"10.1053\/j.ajkd.2025.01.022_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71956-1","article-title":"Severe neurological outcomes after very early bilateral nephrectomies in patients with autosomal recessive polycystic kidney disease (ARPKD)","volume":"10","author":"Burgmaier","year":"2020","journal-title":"Sci Rep"},{"issue":"11","key":"10.1053\/j.ajkd.2025.01.022_bib20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41581-019-0155-2","article-title":"International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people","volume":"15","author":"Gimpel","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2025.01.022_bib21","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.ekir.2023.04.006","article-title":"Clinical characteristics and courses of patients with autosomal recessive polycystic kidney disease-mimicking phenocopies","volume":"8","author":"Halawi","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1053\/j.ajkd.2025.01.022_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2017050483","article-title":"Genetic complexity of autosomal dominant polycystic kidney and liver diseases","volume":"29","author":"Cornec-Le Gall","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"9147","key":"10.1053\/j.ajkd.2025.01.022_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","article-title":"Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group","volume":"353","author":"Hateboer","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1053\/j.ajkd.2025.01.022_bib24","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"15","key":"10.1053\/j.ajkd.2025.01.022_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138724","article-title":"The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD","volume":"5","author":"Lavu","year":"2020","journal-title":"JCI Insight"},{"issue":"3","key":"10.1053\/j.ajkd.2025.01.022_bib26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2215\/CJN.11100720","article-title":"Patients with protein-truncating PKD1 mutations and mild ADPKD","volume":"16","author":"Lanktree","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2025.01.022_bib27","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","article-title":"Mutations in GANAB, encoding the glucosidase II alpha subunit, cause autosomal-dominant polycystic kidney and liver disease","volume":"98","author":"Porath","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1053\/j.ajkd.2025.01.022_bib28","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ajhg.2018.03.013","article-title":"Monoallelic mutations to DNAJB11 cause atypical autosomal-dominant polycystic kidney disease","volume":"102","author":"Cornec-Le Gall","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1053\/j.ajkd.2025.01.022_bib29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2215\/CJN.0000000000000122","article-title":"Risk severity model for pediatric autosomal dominant polycystic kidney disease using 3D ultrasound volumetry","volume":"18","author":"Breysem","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2025.01.022_bib30","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.kint.2023.07.021","article-title":"Certain heterozygous variants in the kinase domain of the serine\/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease","volume":"104","author":"Claus","year":"2023","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2025.01.022_bib31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000539176","article-title":"The first pediatric case of an IFT140 heterozygous deletion causing autosomal dominant polycystic kidney disease: case report","volume":"14","author":"Seeman","year":"2024","journal-title":"Case Rep Nephrol Dial"},{"issue":"4","key":"10.1053\/j.ajkd.2025.01.022_bib32","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ymgme.2011.09.001","article-title":"Hepatorenal findings in obligate heterozygotes for autosomal recessive polycystic kidney disease","volume":"104","author":"Gunay-Aygun","year":"2011","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1053\/j.ajkd.2025.01.022_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng833","article-title":"The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein","volume":"30","author":"Ward","year":"2002","journal-title":"Nat Genet"},{"issue":"5","key":"10.1053\/j.ajkd.2025.01.022_bib34","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/340448","article-title":"PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats","volume":"70","author":"Onuchic","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1053\/j.ajkd.2025.01.022_bib35","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.kint.2021.04.019","article-title":"Refining genotype-phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1 gene variants","volume":"100","author":"Burgmaier","year":"2021","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ajkd.2025.01.022_bib36","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ng.3871","article-title":"Mutations in DZIP1L, which encodes a ciliary-transition-zone protein, cause autosomal recessive polycystic kidney disease","volume":"49","author":"Lu","year":"2017","journal-title":"Nat Genet"},{"issue":"1","key":"10.1053\/j.ajkd.2025.01.022_bib37","article-title":"Cystin genetic variants cause autosomal recessive polycystic kidney disease associated with altered Myc expression","volume":"11","author":"Yang","year":"2021","journal-title":"Sci Rep"},{"issue":"7","key":"10.1053\/j.ajkd.2025.01.022_bib38","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1681\/ASN.2009101070","article-title":"Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD","volume":"21","author":"Vujic","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2025.01.022_bib39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jamapediatrics.2017.3938","article-title":"Perinatal diagnosis, management, and follow-up of cystic renal diseases: a clinical practice recommendation with systematic literature reviews","volume":"172","author":"Gimpel","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"2","key":"10.1053\/j.ajkd.2025.01.022_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1681\/ASN.0000000000000253","article-title":"State of the science and ethical considerations for preimplantation genetic testing for monogenic cystic kidney diseases and ciliopathies","volume":"35","author":"Thompson","year":"2024","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2025.01.022_bib41","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1053\/j.ajkd.2020.08.012","article-title":"Ciliopathies and the kidney: a review","volume":"77","author":"McConnachie","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2025.01.022_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cca.2022.01.012","article-title":"Prenatal diagnosis and outcome of fetal hyperechogenic kidneys in the era of antenatal next-generation sequencing","volume":"528","author":"Deng","year":"2022","journal-title":"Clin Chim Acta"},{"issue":"6","key":"10.1053\/j.ajkd.2025.01.022_bib43","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/uog.22121","article-title":"Perinatal and infant outcome of fetuses with prenatally diagnosed hyperechogenic kidneys","volume":"57","author":"Yulia","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"8","key":"10.1053\/j.ajkd.2025.01.022_bib44","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pd.4112","article-title":"Prenatal diagnosis of multicystic dysplastic kidney disease in the second trimester screening","volume":"33","author":"Al","year":"2013","journal-title":"Prenat Diagn"},{"issue":"2","key":"10.1053\/j.ajkd.2025.01.022_bib45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejmg.2005.02.003","article-title":"Prenatal detection of congenital renal malformations by fetal ultrasonographic examination: an analysis of 709,030 births in 12 European countries","volume":"48","author":"Wiesel","year":"2005","journal-title":"Eur J Med Genet"},{"issue":"2","key":"10.1053\/j.ajkd.2025.01.022_bib46","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/pd.6517","article-title":"Fetal hyperechoic kidneys: Diagnostic considerations and genetic testing strategies","volume":"44","author":"Hertenstein","year":"2024","journal-title":"Prenat Diagn"},{"issue":"2","key":"10.1053\/j.ajkd.2025.01.022_bib47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/pd.6424","article-title":"Characterization of the prenatal renal phenotype associated with 17q12, HNF1B, microdeletions","volume":"44","author":"Verscaj","year":"2024","journal-title":"Prenat Diagn"},{"key":"10.1053\/j.ajkd.2025.01.022_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13039-019-0459-8","article-title":"Targeted capture enrichment followed by NGS: development and validation of a single comprehensive NIPT for chromosomal aneuploidies, microdeletion syndromes and monogenic diseases","volume":"12","author":"Koumbaris","year":"2019","journal-title":"Mol Cytogenet"},{"issue":"1","key":"10.1053\/j.ajkd.2025.01.022_bib49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pd.6720","article-title":"Combined cell-free DNA screening for aneuploidies and selected single-gene disorders for pregnancies with sonographically detected fetal anomalies: detection rate and residual risk","volume":"45","author":"Luong","year":"2025","journal-title":"Prenat Diagn"},{"issue":"8-9","key":"10.1053\/j.ajkd.2025.01.022_bib50","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.placenta.2006.11.009","article-title":"Amniotic fluid water dynamics","volume":"28","author":"Beall","year":"2007","journal-title":"Placenta"},{"issue":"1","key":"10.1053\/j.ajkd.2025.01.022_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pedneo.2016.04.001","article-title":"Pulmonary hypoplasia induced by oligohydramnios: findings from animal models and a population-based study","volume":"58","author":"Wu","year":"2017","journal-title":"Pediatr Neonatol"},{"issue":"4","key":"10.1053\/j.ajkd.2025.01.022_bib52","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.clp.2022.08.001","article-title":"Fetal therapy for renal anhydramnios","volume":"49","author":"Miller","year":"2022","journal-title":"Clin Perinatol"},{"key":"10.1053\/j.ajkd.2025.01.022_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2024.114151","article-title":"Long-term outcomes, including fetal and neonatal prognosis, of renal oligohydramnios: a retrospective study over 22 years","author":"Nishi","year":"2024","journal-title":"J Pediatr"},{"key":"10.1053\/j.ajkd.2025.01.022_bib54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jpeds.2018.03.052","article-title":"Risk factors for early dialysis dependency in autosomal recessive polycystic kidney disease","volume":"199","author":"Burgmaier","year":"2018","journal-title":"J Pediatr"},{"issue":"S1","key":"10.1053\/j.ajkd.2025.01.022_bib55","first-page":"e156","article-title":"Severe fetal CAKUT (congenital anomalies of the kidneys and urinary tract), prenatal consultations, and initiation of neonatal dialysis","volume":"41","author":"Sanderson","year":"2024","journal-title":"Am J Perinatol"},{"issue":"4","key":"10.1053\/j.ajkd.2025.01.022_bib56","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00467-023-06137-z","article-title":"Congenital anomalies of the kidney and urinary tract: antenatal diagnosis, management and counselling of families","volume":"39","author":"Walker","year":"2024","journal-title":"Pediatr Nephrol"},{"issue":"31 suppl","key":"10.1053\/j.ajkd.2025.01.022_bib57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0968-8080(08)31382-2","article-title":"Termination of pregnancy for fetal abnormality: the perspective of a parent support organisation","volume":"16","author":"Fisher","year":"2008","journal-title":"Reprod Health Matters"},{"issue":"7","key":"10.1053\/j.ajkd.2025.01.022_bib58","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/pd.4836","article-title":"Prenatal counselling for congenital anomalies: a systematic review","volume":"36","author":"Marokakis","year":"2016","journal-title":"Prenat Diagn"},{"issue":"6","key":"10.1053\/j.ajkd.2025.01.022_bib59","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s004670050794","article-title":"Non-compliance and transfer from paediatric to adult transplant unit","volume":"14","author":"Watson","year":"2000","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2025.01.022_bib60","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1399-3046.2010.01299.x","article-title":"Adherence to the immunosuppressive regimen in pediatric kidney transplant recipients: a systematic review","volume":"14","author":"Dobbels","year":"2010","journal-title":"Pediatr Transplant"},{"issue":"10","key":"10.1053\/j.ajkd.2025.01.022_bib61","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00467-011-1981-z","article-title":"Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA)","volume":"26","author":"Watson","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2025.01.022_bib62","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1542\/peds.111.5.1072","article-title":"Autosomal recessive polycystic kidney disease: the clinical experience in North America","volume":"111","author":"Guay-Woodford","year":"2003","journal-title":"Pediatrics"},{"key":"10.1053\/j.ajkd.2025.01.022_bib63","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12882-015-0002-z","article-title":"Rationale, design and objectives of ARegPKD, a European ARPKD registry study","volume":"16","author":"Ebner","year":"2015","journal-title":"BMC Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2025.01.022_bib64","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.2215\/CJN.11331114","article-title":"Pravastatin therapy and biomarker changes in children and young adults with autosomal dominant polycystic kidney disease","volume":"10","author":"Klawitter","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2025.01.022_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00523-z","article-title":"Early childhood height-adjusted total kidney volume as a risk marker of kidney survival in ARPKD","volume":"11","author":"Burgmaier","year":"2021","journal-title":"Sci Rep"},{"issue":"7","key":"10.1053\/j.ajkd.2025.01.022_bib66","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.ekir.2022.04.095","article-title":"Phenotypic variability in siblings with autosomal recessive polycystic kidney disease","volume":"7","author":"Ajiri","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1053\/j.ajkd.2025.01.022_bib67","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jpeds.2015.12.079","article-title":"Chronic Kidney Disease in Children (CKiD) Study. Kidney disease progression in autosomal recessive polycystic kidney disease","volume":"171","author":"Dell","year":"2016","journal-title":"J Pediatr"},{"issue":"1-2","key":"10.1053\/j.ajkd.2025.01.022_bib68","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ymgme.2020.08.006","article-title":"Prospective evaluation of kidney and liver disease in autosomal recessive polycystic kidney disease-congenital hepatic fibrosis","volume":"131","author":"Abdul Majeed","year":"2020","journal-title":"Mol Genet Metab"},{"issue":"9","key":"10.1053\/j.ajkd.2025.01.022_bib69","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.ekir.2019.05.015","article-title":"ADPedKD: a global online platform on the management of children with ADPKD","volume":"4","author":"De Rechter","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"10","key":"10.1053\/j.ajkd.2025.01.022_bib70","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.2215\/CJN.01010211","article-title":"Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease","volume":"6","author":"Helal","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2025.01.022_bib71","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1046\/j.1523-1755.2001.0590051654.x","article-title":"Progression of autosomal-dominant polycystic kidney disease in children","volume":"59","author":"Fick-Brosnahan","year":"2001","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2025.01.022_bib72","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2025.01.022_bib73","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1148\/radiol.2021202302","article-title":"Rapid B(1)-insensitive MR fingerprinting for quantitative kidney imaging","volume":"300","author":"MacAskill","year":"2021","journal-title":"Radiology"},{"issue":"12","key":"10.1053\/j.ajkd.2025.01.022_bib74","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1016\/j.ekir.2024.09.006","article-title":"Multimodal magnetic resonance imaging assessments of kidney disease severity in autosomal recessive polycystic kidney disease","volume":"9","author":"MacAskill","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"10","key":"10.1053\/j.ajkd.2025.01.022_bib75","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/j.ekir.2023.07.004","article-title":"Imaging biomarkers in young patients with ADPKD","volume":"8","author":"Yang","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"10","key":"10.1053\/j.ajkd.2025.01.022_bib76","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.ekir.2024.07.012","article-title":"Biomarkers of kidney disease progression in ADPKD","volume":"9","author":"Ghanem","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.ajkd.2025.01.022_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100596","article-title":"Polycystic kidney disease drug development: a conference report","volume":"5","author":"Liebau","year":"2023","journal-title":"Kidney Med"},{"issue":"5","key":"10.1053\/j.ajkd.2025.01.022_bib78","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000502999","article-title":"Rapid progression of autosomal dominant polycystic kidney disease: urinary biomarkers as predictors","volume":"50","author":"Messchendorp","year":"2019","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2025.01.022_bib79","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40348-021-00131-x","article-title":"Translational research approaches to study pediatric polycystic kidney disease","volume":"8","author":"Liebau","year":"2021","journal-title":"Mol Cell Pediatr"},{"issue":"3","key":"10.1053\/j.ajkd.2025.01.022_bib80","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/ndt\/gfx043","article-title":"Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial","volume":"33","author":"Torres","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1053\/j.ajkd.2025.01.022_bib81","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat Med"},{"issue":"5","key":"10.1053\/j.ajkd.2025.01.022_bib82","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/ndt\/gfab312","volume":"37","author":"Muller","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1053\/j.ajkd.2025.01.022_bib83","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.04870422","article-title":"Perspectives on drug development in autosomal recessive polycystic kidney disease","volume":"17","author":"Liebau","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2025.01.022_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109495","article-title":"Metabolic reprogramming and the role of mitochondria in polycystic kidney disease","volume":"67","author":"Podrini","year":"2020","journal-title":"Cell Signal"},{"key":"10.1053\/j.ajkd.2025.01.022_bib85","article-title":"Is there a functional role of mitochondrial dysfunction in the pathogenesis of ARPKD?","volume":"8","author":"Liebau","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10.1053\/j.ajkd.2025.01.022_bib86","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/CIRCRESAHA.121.319819","article-title":"What level of blood pressure is concerning in childhood?","volume":"130","author":"Flynn","year":"2022","journal-title":"Circ Res"},{"issue":"12","key":"10.1053\/j.ajkd.2025.01.022_bib87","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1007\/s00467-021-05192-8","article-title":"Systematic review on outcomes used in clinical research on autosomal recessive polycystic kidney disease-are patient-centered outcomes our blind spot?","volume":"36","author":"Gimpel","year":"2021","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2025.01.022_bib88","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2215\/CJN.08950621","article-title":"Curcumin therapy to treat vascular dysfunction in children and young adults with ADPKD: a randomized controlled trial","volume":"17","author":"Nowak","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2025.01.022_bib89","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2215\/CJN.02810608","article-title":"Prospective change in renal volume and function in children with ADPKD","volume":"4","author":"Cadnapaphornchai","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2025.01.022_bib90","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.0000000000000022","article-title":"Tolvaptan for children and adolescents with autosomal dominant polycystic kidney disease: randomized controlled trial","volume":"18","author":"Mekahli","year":"2023","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638625007723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638625007723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:12:41Z","timestamp":1778508761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638625007723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0272638625007723"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.01.022","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic Kidney Disease in Children: The Current Status and the Next Horizon","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}